)
Senti Biosciences (SNTI) investor relations material
Senti Biosciences Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Entered into a $4.0 million Senior Secured Convertible Notes agreement with Celadon Partners SPV 24 on August 14, 2026, under a previously announced Securities Purchase Agreement.
Notes terms are detailed in prior 8-K filings from May 1 and May 26, 2026, incorporated by reference.
Contingent value right may pay up to $60.0 million in cash to stockholders, subject to regulatory and sales milestones for SENTI-202.
Voting matters and shareholder proposals
A preliminary proxy statement was filed on July 21, 2026, regarding the issuance of Notes beyond the Exchange Cap and a potential merger transaction involving Celadon.
Definitive proxy materials will be mailed to stockholders for voting on the Subject Transactions.
Board of directors and corporate governance
Directors and executive officers may participate in the solicitation of proxies for the Subject Transactions.
Information on directors, executive officers, and their stock ownership is available in the April 29, 2026, 10-K amendment.
- Q2 net loss narrowed, cash fell, and a merger will leave only early-stage assets and CVRs for shareholders.SNTI
Q2 2026 - Shareholders will vote on a merger offering milestone-based CVRs, not cash, for their shares.SNTI
Proxy filing - Majority of shares registered for resale could shift control and cause significant dilution.SNTI
Registration filing - Shareholders to receive milestone-based CVRs as core assets are spun off in a strategic merger.SNTI
Proxy filing - SENTI-202 demonstrates durable, MRD-negative responses in AML using innovative logic gating technology.SNTI
The Citizens JMP Life Sciences Conference 2025 - Highly dilutive resale of 15.97M shares may shift control and pressure stock price.SNTI
Registration filing - Q1 2026 saw SENTI-202 clinical progress, narrowed net loss, and new $40M financing.SNTI
Q1 2026 - SENTI-202 achieved 50% ORR and 42% CR/CRh with excellent safety in R/R AML Phase 1 trial.SNTI
Corporate presentation - Positive SENTI-202 clinical progress, RMAT status, and $61.4M net loss with $16.4M cash.SNTI
Q4 2025
Next Senti Biosciences earnings date
Next Senti Biosciences earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage